PMID- 10652700 OWN - NLM STAT- MEDLINE DCOM- 20000210 LR - 20151119 IS - 0024-7766 (Print) IS - 0024-7766 (Linking) VI - 32 IP - 4 DP - 1999 Dec TI - Effect of tumor necrosis factor-alpha and interleukin-2 on spleen lymphocyte migration in mouse skin. PG - 166-70 AB - Tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 (IL-2) are reported to enhance lymphocyte binding to endothelial cells in vitro. We examined these two agents on lymphocyte migration in vivo. Spleen lymphocytes were radiolabeled with tritiated uridine (3H-UR) and then injected i.v. into mice. Each cytokine (TNF-alpha or IL-2) or both cytokines were then injected intradermally on the back of mice. The results demonstrated that TNF-alpha stimulates lymphocyte migration in vivo in dose-dependent fashion. Kinetic analysis demonstrated that migration with TNF-alpha started at 3 h, peaked at 6 h, followed by a gradual decline back to baseline at 24 h. IL-2, on the other hand, was nearly inactive, and did not augment lymphocyte migration over and above that induced by TNF-alpha when both cytokines were injected together. FAU - Sun, J AU - Sun J AD - Department of Anatomy, Shandong Medical University, Jinan, People's Republic of China. FAU - Liu, Z AU - Liu Z FAU - Bi, Y AU - Bi Y FAU - Guo, Z AU - Guo Z FAU - Hua, T AU - Hua T FAU - Ding, Z AU - Ding Z LA - eng PT - Journal Article PL - United States TA - Lymphology JT - Lymphology JID - 0155112 RN - 0 (Interleukin-2) RN - 0 (Tumor Necrosis Factor-alpha) RN - 10028-17-8 (Tritium) RN - WHI7HQ7H85 (Uridine) SB - IM MH - Animals MH - Cell Movement/*immunology MH - Dose-Response Relationship, Drug MH - Drug Interactions MH - Female MH - Interleukin-2/immunology/*pharmacology MH - Lymphocytes/immunology MH - Mice MH - Mice, Inbred BALB C MH - Spleen/*immunology MH - Tritium MH - Tumor Necrosis Factor-alpha/immunology/*pharmacology MH - Uridine EDAT- 2000/02/01 00:00 MHDA- 2000/02/01 00:01 CRDT- 2000/02/01 00:00 PHST- 2000/02/01 00:00 [pubmed] PHST- 2000/02/01 00:01 [medline] PHST- 2000/02/01 00:00 [entrez] PST - ppublish SO - Lymphology. 1999 Dec;32(4):166-70.